Healthcare -
Biotechnology - NASDAQ - US
$ 6.16
-0.324 %
$ 276 M
Market Cap
-11.41
P/E
YMAB - TOTAL LIABILITIES
Total Liabilities YMAB - Y-mAbs Therapeutics, Inc.
26.9 M
LAST VALUE
-9.30%
2 YEAR CAGR
18.72%
5 YEAR CAGR
0.00%
10 YEAR CAGR